Biogen, Inc. (BIIB)
176.05
-0.35
(-0.20%)
USD |
NASDAQ |
Dec 31, 16:00
174.55
-1.50
(-0.85%)
After-Hours: 20:00
Biogen Price: 176.05 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 327.34 |
| Eli Lilly & Co. | 1075.02 |
| Merck & Co., Inc. | 105.28 |
| Pfizer Inc. | 24.90 |
| Stoke Therapeutics, Inc. | 31.68 |
Price Related Metrics
| PE Ratio | 16.06 |
| PS Ratio | 2.664 |
| Price to Book Value | 1.418 |
| Price to Free Cash Flow | 11.41 |
| Earnings Yield | 6.23% |
| Market Cap | 25.83B |
| Operating PE Ratio | 10.58 |
| Normalized PE Ratio | 14.23 |